Dr. Rikhav Gala is a pharmaceutical scientist with extensive expertise in vaccine research, drug development, and advanced formulations. He holds a Ph.D. and M.Sc. in Industrial Pharmaceutical Sciences and currently leads innovation programs at Pfizer, where his work focuses on translating scientific insights into impactful therapies that improve patient lives globally. Dr. Gala has authored multiple peer-reviewed manuscripts, is an inventor on patents in the field of drug delivery and formulations, and has presented his work at national and international scientific conferences. His research and leadership emphasize leveraging prior knowledge in drug delivery and formulation development to accelerate innovation, ensure quality, and optimize outcomes.